P
How
efficacious
is the vaccine? A large phase 3 trial in Brazil showed that two doses, administered at an interval of 14 days, had an
efficacy
of 51% against symptomatic SARS-CoV-2 infection, 100% against severe COVID-19, and 100% against hospitalization starting 14 days after receiving the second dose.